The fifth pharmaceutical company sued by Oregon’s attorney general and dozens of other state attorneys general for violating federal antitrust laws in the last decade agreed to settle, this time for nearly $30 million. Oregon Attorney General Dan Rayfield announced Wednesday that generic drug manufacturer Glenmark, accused of participating in an elaborate price fixing scheme […]
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a current print subscriber, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
